EarningsQ3 2025 Earnings Report

Novartis (NVSN) Q3 2025 Earnings Report

0 Followers

MX:NVSN Q3 2025 EPS Results

Actual EPS$40.86

Consensus EPS$41.28

Beat/MissMissed by -$0.42

One Year Ago EPS$37.41

Actual Revenue$252.00B

Expected Revenue$251.98B

Beat/MissBeat by +$13.53M

YoY Revenue Growth+7.04%

QuarterQ3 2025

Date10/28/2025

TimeBefore Open

Conference CallTuesday, October 28, 2025

MX:NVSN Upcoming Earnings

Novartis's next earnings date is estimated for October 27, 2026, based on past reporting schedules.

MX:NVSN Q3 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 27, 2026	2026 (Q3)	41.10 / -	40.862	―
Jul 21, 2026	2026 (Q2)	39.45 / 43.77	43.949	-0.41% (-0.18)
Apr 28, 2026	2026 (Q1)	38.10 / 36.14	41.406	-12.72% (-5.27)
Feb 04, 2026	2025 (Q4)	36.01 / 36.87	35.958	2.53% (+0.91)
Oct 28, 2025	2025 (Q3)	41.28 / 40.86	37.411	9.22% (+3.45)
Jul 17, 2025	2025 (Q2)	42.70 / 43.95	35.777	22.84% (+8.17)
Apr 29, 2025	2025 (Q1)	38.39 / 41.41	32.689	26.67% (+8.72)
Jan 31, 2025	2024 (Q4)	32.78 / 35.96	27.786	29.41% (+8.17)
Oct 29, 2024	2024 (Q3)	35.20 / 37.41	31.6	18.39% (+5.81)
Jul 18, 2024	2024 (Q2)	33.60 / 35.78	31.491	13.61% (+4.29)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed